Method for efficientlyobtaining mesenchymal stem cells from umbilical cord tissues

A technology of umbilical cord tissue and mesenchymal stem cells, applied in bone/connective tissue cells, tissue culture, animal cells, etc., can solve the problems of time-consuming and damage, achieve strong stem cell characteristics, avoid adverse reactions, and shorten the acquisition time.

Inactive Publication Date: 2017-01-04
中卫华医(北京)生物科技有限公司 +1
View PDF3 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The tissue block adhesion method mainly uses the adhesion and adhesion ability of MSCs to separate and purify MSCs cells during the adherent culture process, but the tissue block adhesion method needs to cut the umbilical cord tissue, and the mechanical external force will damage the tissue cells; The umbilical cord is a tissue rich in collagen and glucosamine, so the umbilical cord tissue is usually digested with collagenase to obtain MSCs. Enzymatic digestion can obtain a more complete cell structure and more MSCs, but most enzyme digestion methods take more time , the enzyme concentration and digestion time are very important for the isolation and culture of MSCs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for efficientlyobtaining mesenchymal stem cells from umbilical cord tissues
  • Method for efficientlyobtaining mesenchymal stem cells from umbilical cord tissues
  • Method for efficientlyobtaining mesenchymal stem cells from umbilical cord tissues

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Embodiment 1, the steps of the method for efficiently obtaining mesenchymal stem cells from umbilical cord tissue in the present invention are: (1) Pretreatment of umbilical cord tissue: a healthy full-term neonatal umbilical cord, which is about 20 cm close to the baby's end, is placed in a 1% double antibody in normal saline preservation solution, and transported as soon as possible in a 4°C ice box. Take out the umbilical cord in a biological safety cabinet, place it in a 10cm petri dish, cut it into 2-3cm long pieces, and wash it repeatedly with DPBS containing 1% double antibody until there is no obvious blood clot. Cut the umbilical cord longitudinally and remove the blood vessels. Rinse the tissue block with DPBS containing 1% double antibody, and cut the tissue block to 1-2mm3 with ophthalmic scissors. (2) Separation of umbilical cord MSCs cells: the shredded tissue pieces were collected into a six-well plate, added with 0.25% trypsin, and pre-digested on a sha...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to amethod for efficientlyobtaining mesenchymal stem cells from umbilical cord tissues and aims at solving the problems of the long obtaining time and low efficiency of an existing method. The method comprises the steps that primary isolation of umbilical cord mesenchymal stem cells is performed: cleaned and cut umbilical cord tissue blocks are predigested by using trypsin and then digestive juice is removed, repeated flushing is performed with DPBS, then digestion is performed on a water bath shaker of 37 DEG C by using collagenase I digestive juice, a complete culture solution is added to the filtrate filtered by a cell strainer to terminate digestive centrifugal separation so as to obtain primary mesenchymal stem cell; residual tissue blocks are collected after filtration, and re-digestion is performed to obtain primary mesenchymal stem cells; the mesenchymal stem cells are inoculated in the complete culture solution, and standing and culture is performed in 5% CO2 culture box at the temperature of 37 DEG C; a culture solution is replaced for one time at intervals of several days; culture multiplication is performed: when the primary cells grow to be 80% and converge, TrypLE heavy suspension cells are subjected to culture multiplication in a serum-free culture solution. The method has the advantages of efficiently obtaining mesenchymal stem cells, and the obtained mesenchymal stem cells have highcell activity and differentiation potential.

Description

technical field [0001] The invention relates to a method for obtaining umbilical cord mesenchymal stem cells, in particular to a method for efficiently obtaining mesenchymal stem cells from umbilical cord tissue. Background technique [0002] Mesenchymal stem cells (MSCs) are a type of stem cells, derived from the mesoderm in the early stage of development, have high differentiation potential, and are widely found in connective tissues such as bone marrow, fat, and umbilical cord blood in the human body and in the mesenchyme of organs. It has the potential of self-renewal, high proliferation and multi-directional differentiation. Under specific induction conditions in vivo and in vitro, it can differentiate into fat, bone, cartilage, muscle, cardiac muscle, endothelial and other tissue cells. With differentiation potential, it has gradually become a cell source of great practical value in the field of tissue engineering and gene therapy, and has attracted more and more atten...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/0775
CPCC12N5/0668C12N2500/90
Inventor 李亚平王晶谷广其邱丽媛赵进军何文丽
Owner 中卫华医(北京)生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products